Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Reexamination Certificate
2003-02-03
2011-10-11
Padmanabhan, Sreeni (Department: 1627)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
C424S774000
Reexamination Certificate
active
08034843
ABSTRACT:
Cannabinoids, in particular CBD and CBDA and their acid derivatives are provided for use as an active pharmaceutical substance in the treatment of nausea, vomiting, emesis, motion sickness. In particular extracts of cannabis plants are presented which are rich in these substances and suitable for pharmaceutical use.
REFERENCES:
patent: 4847290 (1989-07-01), Burstein
patent: 5434295 (1995-07-01), Mechoulam et al.
patent: 5874459 (1999-02-01), Makriyannis et al.
patent: 6113940 (2000-09-01), Brooke et al.
patent: 6162829 (2000-12-01), Burstein
patent: 6328992 (2001-12-01), Brooke et al.
patent: 6383513 (2002-05-01), Watts et al.
patent: 6403126 (2002-06-01), Webster et al.
patent: 2386322 (2003-09-01), None
patent: WO 93/05031 (1993-03-01), None
patent: WO 99/52524 (1999-10-01), None
patent: WO 01/03668 (2001-01-01), None
patent: WO 01/95899 (2001-12-01), None
patent: WO 01-98289 (2001-12-01), None
patent: WO 02/32420 (2002-04-01), None
patent: WO 02-064109 (2002-08-01), None
patent: WO 02/069993 (2002-09-01), None
patent: WO 03/037306 (2003-05-01), None
El-Darawy et al. (1972) Studies on Hashish, Isolation & Identification of Cannabinols and Effect of Certain Factors. Qual. Plant. Mater. Veg. XX1, 4, pp. 311-325.
Baek et al. (1985) Boron Trifluoride Etherate on Alimina. A Modified Lewis Acid Reagent. An Improved Synthesis of Cannabidiol. Tetrahedron Letters. vol. 26, No. 8, pp. 1083-1086.
Watanabe et al. Biol. Pharm. Bull. Aug. 1996, vol. 19, No. 8, pp. 1109-1111.
Koch, KL. Illusory self-motion and motion sickness: a model for grain-gut interaction and nausea. DigDIS Sci. Aug. 1999, vol. 44, 8 Suppl. pp. 53S-57S, abstract submitted only.
The United Kingdom Parliament, Select Committee on Science and Technology Ninth Report (1998) at http://www.parliament.the-stationery-office.co.uk/pa/Id199798/Idselect/Idsctech/151/15101.htm.
The United Kingdom Parliament, Select Committee on Science and Technology Second Report (Mar. 14, 2001) at http://www.publications.parliament.uk/pa/Id200001/Idselect/Idsctech/50/5001.htm.
Darmani, N.A., “The potent emetogenic effects of the endocannabinoid, 2-AG (2-Arachidonoylglycerol) are blocked by Δ9-tetrahydrocannabinol and other cannabinoids,”The Journal of Pharmacology and Experimental Therapeutics2002; 300(1):34-42.
“Cannabinoid” at http://en.wikipedia.org/wiki/Cannabinoid, downloaded on Aug. 10, 2009 from Wikipedia, the free encyclopedia (12 pages).
Adams, R. et al., “Structure of Cannabidiol. XII. Isomerization to Tetrahydrocannabinols,”Journal of the American Chemical Society1941; 63:2209-2213.
BIOSIS Abstract Acct. No. PREV200200002690 of Society for Neuroscience Abstracts, vol. 27, No. 2, Nov. 2002, Darmani, N.A., “The endogenous cannabinoid 2-arachidonoylglycerol induces vomiting: Blockade by marijuana and its synthetic analogs,” p. 2126.
Burstein, S.H. “The cannabinoid acids: Nonpsychoactive derivatives with therapeutic potential,”Pharmacology and Therapeutics1999; 82(1):87-96.
Medline Abstract Acc. No. NLM11752094 of the Journal of Pharmacology and Experimental Therapeutics, vol. 300, No. 1, Jan. 2002, Darmani, N.A., “The potent emetogenic effects of the endocannabinoid, 2-AG (2-arachidonoylglycerol) are blocked by delta(9)-tetrahydrocannabinol and other cannabinoids,” pp. 34-42.
Molnar, J. et al., “Membrane associated antitumor effects of crocine-ginsenoside- and cannabinoid derivatives,”Anticancer ResearchMar. 2000; 20(2A):861-868.
Parker, L. et al., “Cannabidiol, a non-psychoactive component of cannabis and its synthetic dimethylheptyl homolog suppress nausea in an experimental model with rats,”Neuroreport. Apr. 16, 2002; 13(5):567-570.
Yamamoto, I. et al., “Recent advances in the metabolism of cannabinoids,”International Journal of Biochemistry and Cell Biology1995; 27(8):741-746.
Yotoriyama, M. et al., “Comparison of pharmacological activity in mice of different cannabis extracts from CBDA and THCA strains,”Esei Kagaku1991; 37(6):507-511.
Javid Farideh Afshin
Whittle Brian
GW Pharma Limited
Jean-Louis Samira
Padmanabhan Sreeni
Wolf Greenfield & Sacks P.C.
LandOfFree
Compositions comprising cannabinoids for treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions comprising cannabinoids for treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions comprising cannabinoids for treatment of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4280652